These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24304197)

  • 21. MMPs in the trabecular meshwork: promising targets for future glaucoma therapies?
    De Groef L; Van Hove I; Dekeyster E; Stalmans I; Moons L
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7756-63. PubMed ID: 24265206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations.
    Andrés-Guerrero V; García-Feijoo J; Konstas AG
    Adv Ther; 2017 May; 34(5):1049-1069. PubMed ID: 28349508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of experimental glaucoma on vitreous volume.
    Lazar M; Ganor E; Nemet P; Godel V
    Metab Pediatr Syst Ophthalmol; 1982; 6(3-4):347-8. PubMed ID: 6192314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of biophysical attributes of the ocular trabecular meshwork associated with glaucoma on the cell response to therapeutic agents.
    McKee CT; Wood JA; Shah NM; Fischer ME; Reilly CM; Murphy CJ; Russell P
    Biomaterials; 2011 Mar; 32(9):2417-23. PubMed ID: 21220171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eyes on new product development: trabecular meshwork.
    Novack GD
    J Ocul Pharmacol Ther; 2014; 30(2-3):83-4. PubMed ID: 24697264
    [No Abstract]   [Full Text] [Related]  

  • 26. The trabecular meshwork: Structure, function and clinical implications. A review of the literature.
    Buffault J; Labbé A; Hamard P; Brignole-Baudouin F; Baudouin C
    J Fr Ophtalmol; 2020 Sep; 43(7):e217-e230. PubMed ID: 32561029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic and post-genomic effects of anti-glaucoma drugs preservatives in trabecular meshwork.
    Izzotti A; La Maestra S; Micale RT; Longobardi MG; Saccà SC
    Mutat Res; 2015 Feb; 772():1-9. PubMed ID: 25772104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ripasudil: first global approval.
    Garnock-Jones KP
    Drugs; 2014 Dec; 74(18):2211-5. PubMed ID: 25414122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioengineered glaucomatous 3D human trabecular meshwork as an in vitro disease model.
    Torrejon KY; Papke EL; Halman JR; Stolwijk J; Dautriche CN; Bergkvist M; Danias J; Sharfstein ST; Xie Y
    Biotechnol Bioeng; 2016 Jun; 113(6):1357-68. PubMed ID: 26615056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into pathophysiological mechanisms regulating conventional aqueous humor outflow.
    Paulavičiūtė-Baikštienė D; Baršauskaitė R; Janulevičienė I
    Medicina (Kaunas); 2013; 49(4):165-9. PubMed ID: 23985980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of chondroitin sulfate on trabecular meshwork in rabbit eyes: an electron microscopic study.
    Fei PF; Yue BY; Tso MO
    Exp Eye Res; 1984 Nov; 39(5):583-94. PubMed ID: 6440803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of topical H-7 on outflow facility, intraocular pressure, and corneal thickness in monkeys.
    Tian B; Wang RF; Podos SM; Kaufman PL
    Arch Ophthalmol; 2004 Aug; 122(8):1171-7. PubMed ID: 15302658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ripasudil hydrochloride hydrate: targeting Rho kinase in the treatment of glaucoma.
    Inoue T; Tanihara H
    Expert Opin Pharmacother; 2017 Oct; 18(15):1669-1673. PubMed ID: 28893104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model systems for the study of steroid-induced IOP elevation.
    Rybkin I; Gerometta R; Fridman G; Candia O; Danias J
    Exp Eye Res; 2017 May; 158():51-58. PubMed ID: 27450911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular changes in glaucomatous trabecular meshwork. Correlations with retinal ganglion cell death and novel strategies for neuroprotection.
    Saccà SC; Vernazza S; Iorio EL; Tirendi S; Bassi AM; Gandolfi S; Izzotti A
    Prog Brain Res; 2020; 256(1):151-188. PubMed ID: 32958211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between outflow resistance and trabecular meshwork stiffness in mice.
    Wang K; Li G; Read AT; Navarro I; Mitra AK; Stamer WD; Sulchek T; Ethier CR
    Sci Rep; 2018 Apr; 8(1):5848. PubMed ID: 29643342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of Cell Impedance as a Screening Tool to Discover Modulators of Intraocular Pressure.
    Vollmer TR; Zhou EH; Rice DS; Prasanna G; Chen A; Wilson CW
    J Ocul Pharmacol Ther; 2020 Jun; 36(5):269-281. PubMed ID: 32176566
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of prostaglandins on the aqueous humor outflow pathways.
    Weinreb RN; Toris CB; Gabelt BT; Lindsey JD; Kaufman PL
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S53-64. PubMed ID: 12204701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trabecular outflow facility determined by fluorophotometry in human subjects.
    Hayashi M; Yablonski ME; Novack GD
    Exp Eye Res; 1989 May; 48(5):621-5. PubMed ID: 2737260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of levobunolol eyedrops on trabecular outflow of aqueous humor in chronic simple glaucoma].
    Călugăru M
    Klin Monbl Augenheilkd; 1989 Mar; 194(3):164-9. PubMed ID: 2657200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.